Conference Coverage
-
Conference Coverage
Patients with epilepsy may underreport seizures, survey finds
Clinicians may underestimate the number of seizures that go unreported, and this disconnect may contribute to complacency about epilepsy treatment...
-
Conference Coverage
Incidental finding on brain MRI seen in 5% of older patients
Knowing the expected prevalence of such incidental findings in the older general population is “extremely useful” for both researchers and...
-
Conference Coverage
Chronic migraine is associated with changes in the amygdala
Changes in the volume and connectivity of the amygdala are associated with headache frequency and affective states.
-
Conference Coverage
Galcanezumab looks promising for treatment-resistant migraine
The monoclonal antibody reduced the mean number of monthly migraine days in a 3-month open-label extension of the phase 3 CONQUER study.
-
Conference Coverage
Telerehabilitation may be effective in MS
Patients with MS may achieve equivalent benefits and increased cost savings with telerehabilitation, compared with outpatient rehabilitation.
-
Conference Coverage
Most adult epilepsy-related deaths could be avoided
“The overall mortality is not reducing; people are dying young, and neurologists are really not getting involved.”
-
Conference Coverage
Is cannabis gaining acceptance as a treatment for neuropathic pain?
Some evidence supports cannabis as a treatment for neuropathic pain, but not everyone is convinced.
-
Conference Coverage
Newest oral DMTs haven’t yet made a big impact in the MS world
“Now there are six oral DMTs competing among themselves for a relatively limited pool of patients.”
-
Conference Coverage
Herpes zoster infection with MS treatment higher in women?
While MS affects more women than men, the fivefold increase in HZV well exceeds the female-male ratio in MS.
-
Conference Coverage
Cannabis misconceptions still common among MS clinicians
Studies and surveys underscore that misconceptions about cannabis could be common among clinicians and patients.
Literature Review
-
Literature Review
AAN publishes ethical guidance on patient care during the pandemic
The guidance reviews adaptations to inpatient and outpatient care and indicates the need for protocols to allocate scarce medical resources.
-
Literature Review
Framingham risk score may also predict cognitive decline
“In the absence of effective treatments for dementia, we need to monitor and control cardiovascular risk burden as a way to maintain patient’s...
-
Literature Review
COVID-19 neurologic effects: Does the virus directly attack the brain?
There are neurologic sequelae of COVID-19. “We need to be alert to these, and to try to understand the potential long-term consequences.”
-
Literature Review
Huntington’s disease biomarkers appear 24 years before clinical symptoms
Early signs of neurodegeneration despite normal brain function detected in young adult carriers of the Huntington’s disease gene.
News
-
News
FDA approves apomorphine sublingual film for ‘off’ episodes in Parkinson’s disease
This marks the first approval for a sublingual therapy for this indication.